ENDURING INTERNET
Why the Dyslipidemia Guideline Had to Change
From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice - Understanding the New Dyslipidemia Paradigm (Podcast)
The 2026 Multi-Society Dyslipidemia Guideline introduced significant changes; but, this episode isn't just about what's new. It's about why the field decided a change was necessary in the first place.
In the first installment of this four-part CME/CE-accredited series, host Dave Dixon, PharmD, CLS, FNLA sits down with NLA President Dinesh Kalra, MD, FNLA and Salim Virani, MD to unpack the foundational shift from cholesterol-focused care to a broader dyslipidemia paradigm. The conversation covers why atherogenic lipoprotein exposure earlier in life matters, the key clinical misconceptions embedded in the prior guideline, and what clinicians most commonly misunderstand about lipid risk.
This episode is a companion piece to the Month 1 webinar, From Cholesterol to Dyslipidemia: What Changed in the 2026 Guideline? We encourage you to check it out as the two were built to work together
Course Activities
-
Pre-TestAssessment Required
-
PodcastContent Required
-
Post-TestAssessment Required
-
EvaluationEvaluation Required
-
Credit ClaimCredit claim Required